Search Results - "Ulysse, Luckner"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Molecular Imaging of Neurovascular Cell Death in Experimental Cerebral Stroke by PET by Reshef, Ayelet, Shirvan, Anat, Waterhouse, Rikki N, Grimberg, Hagit, Levin, Galit, Cohen, Avi, Ulysse, Luckner G, Friedman, Gad, Antoni, Gunnar, Ziv, Ilan

    Published in Journal of Nuclear Medicine (01-09-2008)
    “…Clinical molecular imaging of apoptosis is a highly desirable yet unmet challenge. Here we provide the first report on (18)F-labeled…”
    Get full text
    Journal Article
  2. 2

    Initial Process Development and Scale-Up of the Synthesis of a Triple Reuptake Inhibitor ALB 109780 by Yang, Qiang, Ulysse, Luckner G, McLaws, Mark D, Keefe, Daniel K, Haney, Brian P, Zha, Congxiang, Guzzo, Peter R, Liu, Shuang

    Published in Organic process research & development (16-03-2012)
    “…Early process development toward a triple reuptake inhibitor is described. Three different routes were evaluated; one of them was optimized and scaled up to…”
    Get full text
    Journal Article
  3. 3

    Process Development and Optimization for Production of a Potassium Ion Channel Blocker, ICA-17043 by Mobele, Bingidimi I, Venkatraman, Sripathy, McNaughton-Smith, Grant, Gibb, Cameron, Ulysse, Luckner G, Lindmark, Carl A, Shaw, Stephen, Marron, Brian, Spear, Kerry, Suto, Mark J

    Published in Organic process research & development (17-08-2012)
    “…A scalable process for the manufacture of a potassium ion channel blocker was developed and optimized. Key features of the process include an optimized…”
    Get full text
    Journal Article
  4. 4

    Process Development and Pilot-Scale Synthesis of New Cyclization Conditions of Substituted Phenylacetamides to Tetrahydroisoquinoline-2-ones Using Eaton’s Reagent by Ulysse, Luckner G, Yang, Qiang, McLaws, Mark D, Keefe, Daniel K, Guzzo, Peter R, Haney, Brian P

    Published in Organic process research & development (15-01-2010)
    “…Tetrahydroisoquinoline is a ubiquitous structural framework presented in numerous pharmacologically relevant molecules. Although accessible by the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A Light‐Activated β‐Turn Scaffold within a Somatostatin Analog: NMR Structure and Biological Activity by Ulysse, Luckner G., Chmielewski, Jean

    Published in Chemical biology & drug design (01-02-2006)
    “…Somatostatin owes its biological activity to the presence of a well‐defined β‐turn centered around the tetrapeptide Phe‐Trp‐Lys‐Thr. We have developed a…”
    Get full text
    Journal Article
  7. 7

    Process Development toward the Pilot Scale Synthesis of the Piperidine-Based Cocaine Analogue and Potent Dopamine and Norepinephrine Reuptake Inhibitor CTDP 31,446 by Mobele, Bingidimi I, Kinahan, Taryn, Ulysse, Luckner G, Gagnier, Steven V, Ironside, Michael D, Knox, Graham S, Mohammadi, Farahnaz

    Published in Organic process research & development (15-09-2006)
    “…(+)-Methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate hydrochloride (CTDP 31,446) is known as a dopamine reuptake inhibitor. This cocaine analogue…”
    Get full text
    Journal Article
  8. 8

    Process Development and Scale-Up of an Hsp90 Inhibitor by Duan, Shengquan, Venkatraman, Sripathy, Hong, Xuechuan, Huang, Kenneth, Ulysse, Luckner, Mobele, Bingidimi I, Smith, Alexander, Lawless, Lawrence, Locke, Andrew, Garigipati, Ravi

    Published in Organic process research & development (16-11-2012)
    “…A scalable process for the manufacture of a Hsp90 inhibitor was developed and optimized. Key features in the seven-step process include a selective SNAr…”
    Get full text
    Journal Article
  9. 9

    Research Article: A Light-Activated beta -Turn Scaffold within a Somatostatin Analog: NMR Structure and Biological Activity by Ulysse, Luckner G, Chmielewski, Jean

    Published in Chemical biology & drug design (01-02-2006)
    “…Somatostatin owes its biological activity to the presence of a well-defined beta -turn centered around the tetrapeptide Phe-Trp-Lys-Thr. We have developed a…”
    Get full text
    Journal Article
  10. 10

    Restricting the flexibility of crosslinked, interfacial peptide inhibitors of HIV-1 protease by Ulysse, Luckner G., Chmielewski, Jean

    Published in Bioorganic & medicinal chemistry letters (17-11-1998)
    “…Interfacial peptides of HIV-1 protease were crosslinked with varying length alkyl-chains containing either a single cis or trans double bond, or a triple bond…”
    Get full text
    Journal Article
  11. 11

    The design and synthesis of a light activatable beta-turn scaffold and its incorporation into cyclic peptides and dimerization inhibitors of HIV-1 protease by Ulysse, Luckner Gerard

    Published 01-01-1996
    “…A light activatable $\beta$-turn scaffold was designed and incorporated into cyclic peptides. The scaffold is an azobenzene molecule capable of adopting two…”
    Get full text
    Dissertation